| Sep 18, 2026Latest represented filing date | UNITED THERAPEUTICS Corp (UTHR)Nasdaq | Current covered snapshotChairperson & CEO · DirectorValuation observation Sep 25, 2026 | Common Stock, par value $0.01 per share: 40,513 sharesCurrent covered company value: $19.26M | Published current ownership snapshotForms represented: 4Owner filingsIssuer filings |
| Jul 16, 2026Filed date | UNITED THERAPEUTICS Corp (UTHR)Nasdaq | AcquisitionSEC code MEffective Jul 15, 2026 · transaction dateReported units 1,718 shares · reported price 135.42 | Common Stock, par value $0.01 per shareReported position after transaction: 42,231 shares | 4 filing0001106578-26-000099 |
| Jul 16, 2026Filed date | UNITED THERAPEUTICS Corp (UTHR)Nasdaq | SaleSEC code SEffective Jul 15, 2026 · transaction dateReported units 80 shares · reported price 521.82 | Common Stock, par value $0.01 per shareReported position after transaction: 42,151 shares | 4 filing0001106578-26-000099 |
| Jul 16, 2026Filed date | UNITED THERAPEUTICS Corp (UTHR)Nasdaq | SaleSEC code SEffective Jul 15, 2026 · transaction dateReported units 120 shares · reported price 523.9733 | Common Stock, par value $0.01 per shareReported position after transaction: 42,031 shares | 4 filing0001106578-26-000099 |
| Jul 16, 2026Filed date | UNITED THERAPEUTICS Corp (UTHR)Nasdaq | SaleSEC code SEffective Jul 15, 2026 · transaction dateReported units 80 shares · reported price 525.425 | Common Stock, par value $0.01 per shareReported position after transaction: 41,951 shares | 4 filing0001106578-26-000099 |
| Jul 16, 2026Filed date | UNITED THERAPEUTICS Corp (UTHR)Nasdaq | SaleSEC code SEffective Jul 15, 2026 · transaction dateReported units 40 shares · reported price 527.55 | Common Stock, par value $0.01 per shareReported position after transaction: 41,911 shares | 4 filing0001106578-26-000099 |
| Jul 16, 2026Filed date | UNITED THERAPEUTICS Corp (UTHR)Nasdaq | SaleSEC code SEffective Jul 15, 2026 · transaction dateReported units 120 shares · reported price 529.6633 | Common Stock, par value $0.01 per shareReported position after transaction: 41,791 shares | 4 filing0001106578-26-000099 |
| Jul 16, 2026Filed date | UNITED THERAPEUTICS Corp (UTHR)Nasdaq | SaleSEC code SEffective Jul 15, 2026 · transaction dateReported units 278 shares · reported price 530.9678 | Common Stock, par value $0.01 per shareReported position after transaction: 41,513 shares | 4 filing0001106578-26-000099 |
| Jul 16, 2026Filed date | UNITED THERAPEUTICS Corp (UTHR)Nasdaq | SaleSEC code SEffective Jul 15, 2026 · transaction dateReported units 800 shares · reported price 532.0593 | Common Stock, par value $0.01 per shareReported position after transaction: 40,713 shares | 4 filing0001106578-26-000099 |
| Jul 16, 2026Filed date | UNITED THERAPEUTICS Corp (UTHR)Nasdaq | SaleSEC code SEffective Jul 15, 2026 · transaction dateReported units 160 shares · reported price 533.2175 | Common Stock, par value $0.01 per shareReported position after transaction: 40,553 shares | 4 filing0001106578-26-000099 |
| Jul 16, 2026Filed date | UNITED THERAPEUTICS Corp (UTHR)Nasdaq | SaleSEC code SEffective Jul 15, 2026 · transaction dateReported units 40 shares · reported price 534.09 | Common Stock, par value $0.01 per shareReported position after transaction: 40,513 shares | 4 filing0001106578-26-000099 |
| Jul 15, 2026Filed date | UNITED THERAPEUTICS Corp (UTHR)Nasdaq | SaleSEC code SEffective Jul 14, 2026 · transaction dateReported units 107 shares · reported price 531.0811 | Common Stock, par value $0.01 per shareReported position after transaction: 40,713 shares | 4 filing0001106578-26-000098 |
| Jul 15, 2026Filed date | UNITED THERAPEUTICS Corp (UTHR)Nasdaq | SaleSEC code SEffective Jul 14, 2026 · transaction dateReported units 200 shares · reported price 532.602 | Common Stock, par value $0.01 per shareReported position after transaction: 40,513 shares | 4 filing0001106578-26-000098 |